Prescriptions for the medication Leucovorin have surged across the United States after the White House publicly referenced the drug as a possible treatment option for certain children with autism. The sudden spike in demand has led to shortages in some pharmacies, leaving many parents struggling to obtain the medication.
Leucovorin, also known as folinic acid, has long been used in medical treatments such as chemotherapy support and certain vitamin deficiency conditions. In recent years, some researchers and physicians have explored its potential benefits for children with Autism Spectrum Disorder, particularly those who may have folate-related metabolic issues.
However, medical experts emphasize that while some small studies have suggested possible improvements in language or behavioral outcomes for specific patients, the treatment remains controversial and is not considered a standard therapy for autism.
After comments highlighting the drug’s potential gained attention, many parents of children with autism began asking doctors about the medication, leading to a sharp increase in prescriptions. Pharmacists in several regions say the sudden demand has strained supply chains, making it difficult for some families to fill prescriptions quickly.
Healthcare professionals are urging caution, stressing that treatment decisions should be made with qualified physicians and based on individual medical evaluations. They warn that widespread demand driven by public statements can sometimes disrupt access for patients who already rely on the drug for other conditions.
Meanwhile, parents seeking the medication say they are contacting multiple pharmacies or waiting weeks for refills as distributors work to restock supplies.
The situation highlights how quickly public discussion of potential treatments can influence demand for medications, sometimes creating unintended shortages while scientific research continues to evaluate their effectiveness.
